Manuka Honey

Manuka honey is a highly valued monofloral honey produced from the nectar of the native New Zealand Leptospermum scoparium shrub. Highly regarded for its non-peroxide antibacterial properties, its clinical potency is authenticated by methylglyoxal (MGO) and Unique Manuka Factor (UMF) ratings. This category hub lists our independent, evidence-first articles, safety dossiers, and retail reviews to separate clinical science from marketing claims.

Start here.

Three cornerstone investigations analyzing the chemistry, safety protocols, and therapeutic efficacy of clinical-grade Manuka.

Raw honeycomb in a wooden frame
Clinical Application

Manuka Honey for Wound and Skin Healing: What the Evidence Shows

Methylglyoxal (MGO) gives Leptospermum scoparium honey an antibacterial profile fundamentally different from standard hydrogen peroxide-based honeys. We examine randomized trials across topical wound barriers, dermatological applications, and oral ingestion.

Product Reference
Comvita UMF 15+ (MGO 514+) Raw Manuka Honey

Sold under the UMF certification scheme, which specifies MGO thresholds on the label. Typical price ranges from about $70 to $95 for an 8.8 oz jar.

By Elena Marsh
Symptom Management

Manuka Honey for a Sore Throat Coming soon

Why medical-grade manuka honey serves as an exceptional high-viscosity mucosal coating to physically shield and soothe sore throat membranes, and what chemical factors dictate potency.

Product Reference
Watson & Son MGO 400+ Manuka Honey

Monofloral New Zealand manuka honey labeled at MGO 400+. Typically priced from about $45 to $60 per 8.8 oz jar.

By Elena Marsh
Grading Systems

MGO and UMF Ratings Explained Coming soon

Demystifying rating scales. We map dihydroxyacetone (DHA) natural maturity conversions, detail the mathematical conversion tables between MGO and UMF values, and outline standard testing protocols.

By Elena Marsh

Deep-Dive Guides

Comprehensive analyses of consumption, safety profiles, and retail standards.

Manuka Grading & Use FAQ

Evidence-first answers to common scientific and consumer grading inquiries regarding Manuka honey.

What does MGO mean in Manuka honey?

MGO stands for methylglyoxal, the naturally occurring organic chemical compound primarily responsible for the non-peroxide antibacterial activity of Manuka honey. It is measured in milligrams per kilogram (mg/kg).

As a standard of comparison, typical wild honey does not possess measurable methylglyoxal activity. Levels above MGO 250+ are considered therapeutically active, whereas high-potency medical dressings often use concentrations exceeding MGO 500+ or 800+.

Is a higher MGO rating always better?

Not necessarily. Selecting the appropriate MGO rating depends entirely on the intended application. For standard culinary sweetening or daily nutritional support, standard ratings from MGO 80+ to MGO 250+ are completely sufficient.

Higher ratings (MGO 400+ up to 800+ or UMF 15+ to 20+) represent highly potent bioactive compounds. These are highly valued for active wound care dressings, skin barrier support, and acute soothing of irritated oral or throat tissue, though they command much higher market prices.

How can I identify genuine, authentic Manuka honey?

Authentic Manuka honey is always packed in New Zealand and tested by laboratory protocols mandated by the New Zealand Ministry for Primary Industries (MPI).

Always check for the presence of a Unique Manuka Factor (UMF) quality trademark or a clearly declared MGO content. Legitimate brands must list their official UMFHA association license number on the label, and reputable retailers publish corresponding batch test analysis sheets matching the jar's serial number.

Is it safe to consume Manuka honey daily?

Yes, healthy adults can safely consume Manuka honey daily as part of a balanced diet. Because all honey is a dense source of natural carbohydrates (primarily fructose and glucose), typical portion sizes should be restricted to 1 or 2 teaspoons daily.

Crucial safety contraindications: Honey of any grade must never be given to infants under 12 months due to the threat of infant botulism. Additionally, individuals with diabetes or chronic insulin-tolerance sensitivities must monitor glycemic responses and consult their medical provider.